Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (NYSE: HUM) is a U.S. healthcare company in the direct health and medical insurance carriers industry, with operations spanning insurance services and CenterWell health care services. News about Humana often centers on its Medicare Advantage and Medicaid activities, partnerships that expand care models, and initiatives that address social determinants of health and health equity.
Recent announcements highlight Humana’s focus on Medicare Advantage, including earnings guidance updates and investor communications disclosed through Form 8-K filings, as well as program-specific developments such as Humana USAA Honor Giveback plans that are designed with veterans’ needs in mind. These co-branded Medicare Advantage plans feature benefits like $0 copays for in-network primary care and in-network mental health services, Part B givebacks and coverage for dental, vision and hearing, while remaining available to any eligible Medicare beneficiary in the covered areas.
Humana news also reflects its emphasis on value-based care and integrated support for complex conditions. The company has announced a partnership with Atlas Oncology Partners to offer a coordinated oncology care model for eligible Humana Medicare Advantage members in Tennessee and Mississippi, bringing together interdisciplinary care teams, care coordination, psychosocial support and advanced supportive care. In parallel, CenterWell Senior Primary Care and Conviva Senior Primary Care have partnered with Thyme Care to provide continuous, oncology-focused support to eligible patients across several states.
Beyond insurance and clinical partnerships, Humana-related coverage includes updates from the Humana Foundation on research into loneliness among underserved boys and food insecurity among seniors, as well as community impact awards through Humana Healthy Horizons in Oklahoma to organizations addressing food, housing and employment needs. Visitors to this page can explore earnings-related updates, ratings actions from agencies such as AM Best, leadership transitions, philanthropic reports and community initiatives that illustrate how Humana combines insurance, care delivery and community investment.
Humana Inc. (NYSE: HUM) has declared a cash dividend of $0.7875 per share, payable on July 29, 2022, to stockholders of record as of June 30, 2022. This dividend reflects the company's commitment to providing value to its shareholders while maintaining a robust financial position. Humana focuses on integrated care solutions aimed at improving health outcomes and lowering costs for its members, contributing to a better quality of life for various communities.
Humana Inc. (NYSE: HUM) has released its 2021 Impact Report, underlining its commitment to Environmental, Social, and Governance (ESG) initiatives. The report highlights significant investments, including over $15 million in caregiver support and an 32% increase in primary care centers to 206. Humana conducted 94,000 medical screenings, serving 1.6 million meals to members in need and achieving 16% reduction in greenhouse gas emissions. The company aims to enhance transparency in future ESG reporting as part of its business strategy.
Humana Inc. (NYSE: HUM) announced a new $25 million investment to enhance affordable housing across the United States, raising its total commitment to $50 million. This investment targets various states including Florida, Georgia, and Illinois, aiming to address housing needs for vulnerable communities. Humana's strategy includes interventions to reduce healthcare costs and improve health outcomes. The funds will be deployed through three syndicated funds utilizing low-income housing tax credits to support construction and rehabilitation of affordable housing.
Humana (NYSE: HUM) hosted the First Pitch, a virtual event linking diverse suppliers with top prime suppliers as part of its Supplier Diversity Mentor Protégé Program. This initiative, active since 2019, aims to enhance opportunities for minority-owned and small businesses. In 2021, Humana invested $345 million in diverse suppliers, a 9% increase from 2020. The event provided participants valuable feedback and potential business opportunities, reinforcing Humana's commitment to fostering relationships that drive innovation and growth.
The Humana Foundation has announced a continued investment of
Humana Inc. (NYSE: HUM) will report its 1Q22 financial results on April 27, 2022, at 6:30 a.m. Eastern time. A conference call will follow at 9:00 a.m. to discuss the results and 2022 earnings guidance. Participants can register in advance for the call via a provided link, and a webcast will be available on Humana's Investor Relations page. The earnings release will include non-GAAP financial measures and a reconciliation to GAAP. Archived presentations will be accessible later on the website.
AM Best has assigned a Long-Term Issue Credit Rating of “bbb-” (Good) to Humana Inc. (HUM) for its recent issuance of $750 million in 3.70% senior unsecured notes due 2029. The outlook for this rating is stable, and Humana's overall financial health remains unchanged. Proceeds will support general corporate purposes and debt management, with Humana aiming for a more conservative long-term debt-to-capital ratio of 35%. Despite elevated financial leverage at 44%, operating cash flow is strong at $2.3 billion, contributing to favorable revenue growth.
Humana Inc. (NYSE: HUM) has successfully completed a public offering of $750 million in senior notes at a 3.700% interest rate, maturing in 2029. The net proceeds, estimated at $741.1 million, will be used for general corporate purposes, including repaying existing debt. Citigroup Global Markets and Morgan Stanley acted as joint book-running managers for the offering. Forward-looking statements caution investors about various risks, including healthcare cost management, government regulation, and potential impacts from the ongoing COVID-19 pandemic.
Humana Inc. (NYSE: HUM) has announced the pricing of a public offering for $750 million in 3.700% senior notes due 2029. The offering is set to close on March 23, 2022, pending standard closing conditions. The company anticipates net proceeds of approximately $741.1 million, which will be used for general corporate purposes, including repaying existing debts. Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC are the joint book-running managers for this offering. This offering is part of an effective shelf registration with the SEC.
Humana has begun transitioning its Kindred at Home brand to CenterWell Home Health, strengthening its commitment to quality home care. This rebranding effort, initiated on March 1, 2022, will occur across seven states initially, with further expansions planned. The change aims to integrate Kindred's home health services into Humana's overall strategy, enhancing care continuity for patients. CenterWell will serve over 350 locations in 38 states, focusing on improving patient health outcomes and providing personalized care to Medicaid and Medicare patients.